|
Search
Collections
Benchmarks
Upload document
Indication
Transthyretin-mediated Amyloidosis With Cardiomyopathy
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 product
Product
Patisiran
Clinical trial
Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) With Cardiomyopathy
Status:
